Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Biomarker Screening Protocol to Support Preliminary Eligibility for Clinical Trials Evaluating Safety and Efficacy of Adoptive T-cell Therapies in Participants With Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05891197
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:38.505963+00:00
Published At
2025-07-01T00:00:00+00:00
Record Updated At
2025-07-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Triple Negative Breast Cancer", "Non-small Cell Lung Cancer", "Non Small Cell Lung Cancer", "Non Small Cell Lung Cancer Metastatic", "Non-Small Cell Carcinoma of Lung, TNM Stage 4", "Advanced Breast Cancer", "Advanced Lung Carcinoma", "NSCLC", "NSCLC, Recurrent", "NSCLC Stage IV", "Relapsed Cancer", "Relapse/Recurrence", "Recurrent Breast Cancer", "Recurrent NSCLC", "Platinum-resistant Ovarian Cancer", "Ovarian Cancer", "Primary Peritoneal Carcinoma", "Fallopian Tube Cancer", "Endometrial Cancer", "Endometrioid Tumor", "High Grade Serous Carcinoma", "Ovarian Epithelial Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-07-01"
protocolSection.identificationModule.nctId
"NCT05891197"
protocolSection.identificationModule.officialTitle
"A Biomarker Screening Protocol to Support Preliminary Eligibility for Clinical Trials Evaluating Safety and Efficacy of Adoptive T-cell Therapies in Participants With Solid Tumors"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Triple Negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • Non-small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Non Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Non Small Cell Lung Cancer Metastatic (protocolSection.conditionsModule.conditions)
  • Non-Small Cell Carcinoma of Lung, TNM Stage 4 (protocolSection.conditionsModule.conditions)
  • Advanced Breast Cancer (protocolSection.conditionsModule.conditions)
  • Advanced Lung Carcinoma (protocolSection.conditionsModule.conditions)
  • NSCLC (protocolSection.conditionsModule.conditions)
  • NSCLC, Recurrent (protocolSection.conditionsModule.conditions)
  • NSCLC Stage IV (protocolSection.conditionsModule.conditions)
  • Relapsed Cancer (protocolSection.conditionsModule.conditions)
  • Relapse/Recurrence (protocolSection.conditionsModule.conditions)
  • Recurrent Breast Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent NSCLC (protocolSection.conditionsModule.conditions)
  • Platinum-resistant Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
  • Fallopian Tube Cancer (protocolSection.conditionsModule.conditions)
  • Endometrial Cancer (protocolSection.conditionsModule.conditions)
  • Endometrioid Tumor (protocolSection.conditionsModule.conditions)
  • High Grade Serous Carcinoma (protocolSection.conditionsModule.conditions)
  • Ovarian Epithelial Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.